China Anesthetic Industry Trends and Growth Analysis to 2015

Research on China Anesthetic Industry, 2015 report is the latest addition to RnRMarketResearch.com industry research reports collection. The report is about 40 pages and provides Data Charts; the report is published in Jun -2015.

In-depth analysis of Anesthetic Industry in China , 2015 Report. With the increasing numbers of domestic surgeries, the market size of Chinese anesthetic also increased a lot. The market size of Chinese anesthetic industry reached nearly RMB 6400 million in 2014, increased by 18.8% from a YoY base. Among which, General anesthesia accounts for around 69% of the total market size.

Complete report available on http://www.rnrmarketresearch.com/research-on-china-anesthetic-industry-2015-market-report.html

The competition of anesthetic in China is steady. High-end market is dominated by oligopoliesm, which maintained the increase level of the industry. Overall, anesthetic market in China is dominated by foreign and affective domestic companies.

Propofol takes the largest amount of usage in Chinese intravenous anesthetic market, the market size is around 770 million in 2014.AZN is the largest supplier of propofol in China, Fresenius ranks the sencond.Due to the fierce competition status, the growth of propofol will probably slow down.

Purchase a Copy of the Report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=392989 (Single User License - US $1000)

As for narcotic analgesics market,fentanyl category products is the leader. Humanwell accounts for most of the market share of fentanyl injection market,and Xian Janssen is the leader in fentanyl transdermal patches.Xianju Pharma's fentanyl transdermal patches have came into market in 2013, but till now the product have not contribute any profit.

In muscle relaxant market, currently there are 4 companies obtained the product approval of cisatracurium.Heng Rui Medicine Co., Ltd accounts for 56% of cisatracurium market, Sino biopharma ranks second with a market share of over 30%....